Bioatla to announce first quarter 2025 financial results and provide business highlights on may 6, 2025

San diego, april 29, 2025 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today announced that it plans to host a conference call and webcast on tuesday, may 6, 2025 at 4:30 p.m. et to discuss its financial results for the first quarter ended march 31, 2025 and provide business highlights.
BCAB Ratings Summary
BCAB Quant Ranking